Trial · NCT07879664
Bipolar Versus Cooled Radiofrequency Ablation for Gonarthrosis
NCT07879664, Not applicable, Not yet recruiting, Saglik Bilimleri Universitesi
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Bipolar Versus Cooled Radiofrequency Ablation for Gonarthrosis. Trials, record NCT07879664. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07879664
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Bipolar Versus Cooled Radiofrequency Ablation for Gonarthrosis
- NCT number
- NCT07879664
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 80 participants, estimated
- Lead sponsor
- Saglik Bilimleri Universitesi
- Conditions
- Gonarthrosis
- Interventions
- Bipolar Radiofrequency Ablation, Cooled Radiofrequency Ablation
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Pain Intensity | Baseline, 3 weeks, 12 weeks, and 24 weeks | Pain intensity was assessed using the Numeric Rating Scale (NRS). Changes in NRS scores from baseline were evaluated after ultrasound-guided bipolar and cooled radiofrequency ablation of the genicular nerves. |
| Primary | Responder Rate Defined as ≥50% Reduction in NRS Scores | Baseline, 3 weeks, 12 weeks, and 24 weeks | Treatment response was defined as a reduction of at least 50% in Numeric Rating Scale (NRS) scores compared with baseline values following treatment. |
| Secondary | Functional improvement | Baseline, 3 weeks, 12 weeks, and 24 weeks | Functional outcomes and quality of life were evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), including total, pain, stiffness, and function subscale scores. |
| Secondary | Change in Quality of Life | Baseline, 3 weeks, 12 weeks, and 24 weeks | Quality of life will be evaluated using the 12-Item Short Form Health Survey (SF-12). Changes in SF-12 scores compared with baseline values will be assessed during follow-up visits. |
| Secondary | Change in Kinesiophobia | Baseline, 3 weeks, 12 weeks, and 24 weeks | Kinesiophobia and fear of movement associated with chronic knee pain will be assessed using the Tampa Scale for Kinesiophobia (TSK). Changes in TSK scores from baseline following treatment will be evaluated during follow-up visits. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07879664
GET https://conductscience.org/api/trials/v1/NCT07879664/registered